CLVLF   $12.0  -2.60% Market Closed

CLINUVEL PHARMS ORD
Last Events:

2023-07-18 Trend pattern changed from восходящий треугольник to расширяющийся канал.

2023-07-18 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-07-18 Signal in MACD changed from bullish weakening to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

2023-07-18 Signal in RSI changed from bearish reversal to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-07-18 Signal in EMA100 changed from bullish reversal to bearish reversal. 2023-02-27 the price crossed down the moving average line and formed a short-term downside trend.

2023-07-18 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-02-27 the price crossed down the moving average line and formed a short-term downside trend.

2023-07-18 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-02-27 the price crossed down the moving average line and formed a short-term downside trend.

2023-07-18 Trend changed from turning down to down and flat.


Current temperature: 1.82
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 12.38
High with % probability:
Analyst Recommendations:
Number of estimates 6
Target Price Mean 17
Mean unverified/preliminary 17 / 17
Target Price Low / High 10 / 26
Median / STD DEV 15 / 8.38
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi - Sell Sell
macd - Sell -
stoch Sell - -
ma20 Sell - Sell
ma50 Sell - -
ma100 Sell Sell -
Candlestick PatternMarch 14, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN AU000000CUV3
ceo Dr. Philippe Jacques Wolgen M.B.A., M.D.
Website https://www.clinuvel.com
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900 and Parvysmelanotide (VLRX001), both alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone to produce cortisol and enables the combat of stress and regulation of immune responses, maintenance of blood pressure, moderation of blood sugar, and regulation of metabolism. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.